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OBJECTIVES The goal of this study was to determine whether outcomes of nonemergent coronary artery
bypass grafting (CABG) differed between low- and high-volume hospitals in patients at
different levels of surgical risk.
BACKGROUND Regionalizing all CABG surgeries from low- to high-volume hospitals could improve surgical
outcomes but reduce patient access and choice. “Targeted” regionalization could be a
reasonable alternative, however, if subgroups of patients that would clearly benefit from care
at high-volume hospitals could be identified.
METHODS We assessed outcomes of CABG at 56 U.S. hospitals using 1997 administrative and clinical
data from Solucient EXPLORE, a national outcomes benchmarking database. Predicted
in-hospital mortality rates for subjects were calculated using a logistic regression model, and
subjects were classified into five groups based on surgical risk: minimal (0.5%), low (0.5%
to 2%), moderate (2% to 5%), high (5% to 20%), and severe (20%). We assessed differences
in in-hospital mortality, hospital costs and length of stay between low- and high-volume
facilities (defined as 200 annual cases) in each of the five risk groups.
RESULTS A total of 2,029 subjects who underwent CABG at 25 low-volume hospitals and 11,615
subjects who underwent CABG at 31 high-volume hospitals were identified. Significant
differences in in-hospital mortality were seen between low- and high-volume facilities in
subjects at moderate (5.3% vs. 2.2%; p  0.007) and high risk (22.6% vs. 11.9%; p  0.0026)
but not in those at minimal, low or severe risk. Hospital costs and lengths of stay were similar
across each of the five risk groups. Based on these results, targeted regionalization of subjects
at moderate risk or higher to high-volume hospitals would have resulted in an estimated 370
transfers and avoided 16 deaths; in contrast, full regionalization would have led to 2,029
transfers and avoided 20 deaths.
CONCLUSIONS Targeted regionalization might be a feasible strategy for balancing the clinical benefits of
regionalization with patients’ desires for choice and access. (J Am Coll Cardiol 2001;38:
1923–30) © 2001 by the American College of Cardiology
Several studies have demonstrated that hospitals that per-
form a small number of coronary artery bypass graft
(CABG) surgeries have higher in-hospital mortality rates
than facilities with greater surgical volumes (1–9). As a
result, some authorities have suggested that all cases of
nonemergent CABG be referred, or “regionalized,” to
high-volume surgical centers (1,10). It is estimated that in
1997 such a referral strategy from low- to high-volume
See page 1931
hospitals might have avoided 258 CABG-related deaths in
California alone (11). However, implementing regionaliza-
tion could result in potential adverse outcomes by limiting
patient choice and access to care, increasing transfer and
travel-related costs and reducing the availability of surgical
services in many locations (12). Furthermore, it is uncertain
how well high-volume surgical centers could accommodate
large numbers of additional cases without creating signifi-
cant delays or lowering the quality of patient care. Conceiv-
ably, a strategy of “targeted regionalization” could balance
these risks and benefits, allowing some cases of CABG to be
performed at low-volume facilities and transferring only
those individuals who would clearly benefit from the spe-
cialized services provided by high-volume hospitals.
Implicit in the concept of targeted regionalization is the
idea that CABG-related outcomes differ at low- and high-
volume hospitals in specific subgroups of patients and not in
all individuals. The fact that patients undergoing CABG are
heterogeneous and vary considerably in disease severity and
surgical risk is consistent with this premise (13). Elective
cases in middle-aged men with no preexisting medical
conditions, for instance, are associated with an extremely
low in-hospital mortality rate (0.5%); in contrast, urgent
cases in 80-year-old women with diabetes mellitus and
chronic renal insufficiency have an estimated in-hospital
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mortality rate of 10% (13). We, therefore, hypothesized
that, while CABG-related outcomes such as in-hospital
mortality and hospital costs would differ substantially be-
tween low- and high-volume facilities in specific subgroups
of patients at high surgical risk, minimal differences would
exist in subjects at low surgical risk. If true, this would
suggest that CABG could be safely performed in low-risk
patients at low-volume centers, thereby indicating that
targeted regionalization is a viable strategy for policy-
makers to consider.
METHODS
Patients and facilities. We used data from Solucient
EXPLORE, a healthcare outcomes benchmarking database
from Solucient, LLC for our analysis. Solucient EXPLORE
contains administrative and clinical data from more than
150 healthcare facilities across the U.S. and has been used in
previous clinical studies evaluating CABG (14,15). Data in
Solucient EXPLORE are abstracted from discharge-based
claim forms that contain demographic and limited clinical
information including age, gender, race, surgical priority,
discharge status and up to 40 diagnoses and 20 procedures
as identified by International Classification of Diseases,
Ninth Edition (ICD-9-CM) codes. Accuracy is ensured
through a routine audit of records for internal inconsisten-
cies or coding errors and includes procedures for identifying
unmapped charge codes and inconsistencies between phy-
sician codes and hospital codes for the same patient admis-
sion.
To identify subjects for our analysis, we searched all
discharge records from the database between January 1,
1997 and December 31, 1997 for one of eight ICD-9-CM
procedure codes for CABG (codes 36.10 to 36.16 and code
36.19). All subjects 35 years or older who had undergone
isolated, nonemergent CABG were included in the final
data set. Subjects who had undergone emergent CABG,
surgeries other than isolated CABG (e.g., concomitant
valve or aortic surgery) or coronary angioplasty and CABG
during the same hospitalization (presumably for complica-
tions of angioplasty) were excluded. After removing poten-
tial patient and hospital identifiers, Solucient provided data
to researchers at the University of Michigan and University
of Washington for unrestricted use and analysis.
Collected data included age, gender, discharge status,
surgical priority (elective vs. urgent), severity of illness,
hospital costs and length of stay. Information on surgical
priority from the claim forms was supplied by the institu-
tions and relied on administrative staff, not the surgeon.
Severity of illness was assessed using the All Patient
Refined-Diagnosis Related Groups (APR-DRG) (3M/HIS
Corporation, Minneapolis, Minnesota), a discharge
abstract-based case-mix measure that subclassifies subjects
within diagnosis related group (DRG) categories (15).
Within each DRG, subjects are categorized into four
severity levels (minor, moderate, major or extreme) based
on: 1) secondary diagnoses (e.g., diabetes mellitus, chronic
obstructive pulmonary disease, hypertension); 2) the com-
plexity of the secondary diagnoses and their interaction with
each other; and 3) the interaction between the secondary
and principal diagnoses. For our analysis, APR-DRGs
subclassified subjects in DRG 106 (hospitalizations of
CABG without cardiac catheterization) and DRG 107
(CABG with cardiac catheterization). The APR-DRG has
been shown to be useful and valid as a predictor of
in-hospital mortality in subjects undergoing CABG
(16,17).
Hospital costs for each subject were estimated using a
comparative costing methodology from Solucient, which
captures both direct and indirect hospital costs from the
in-house accounting system of each facility (14). Hospital
costs are standardized across facilities using a two-tiered
method that allocates costs from: 1) the general ledger to
standardized cost centers and then, 2) to standardized
transaction codes (based on the Medicare Revenue Code)
employing primarily a Relative Value Unit costing method-
ology. Hospital-specific information in the database in-
cluded the size and location of a facility and its annual
CABG volume.
Data analysis. We used a logistic regression model to
calculate predicted risks of in-hospital death for each subject
in the database. The risk model contained four known
predictors of CABG-related in-hospital mortality: age (less
than 50 years old, 50 to 59 years old, 60 to 69 years old, 70
to 79 years old, 80 years or older), gender, surgical priority
and severity of illness (using APR-DRG). Subjects were
divided into five risk groups based on their predicted
likelihood of suffering an in-hospital death: minimal
(0.5%), low (0.5% to 2%), moderate (2% to 5%), high
(5% to20%) and severe (20%). The Hosmer-Lemeshow
goodness-of-fit statistic was used to assess overall fit in the
risk model (18). Model discrimination, or the ability of the
risk model to distinguish between subjects who suffered an
in-hospital death and those who did not, was measured
using the C-index (19).
We classified surgical centers into low- and high-volume
CABG facilities based on an annual volume of 200 non-
emergent cases. This threshold was chosen after a careful
review of the literature and preliminary data analyses. To
determine whether our results were sensitive to the choice of
a specific threshold, we repeated our analyses varying the
threshold from 100 to 300 cases.
We used chi-square tests to assess for differences between
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in-hospital mortality rates at low- and high-volume facilities
and supplemented these tests with odds ratios and 95%
confidence intervals. Differences in hospital costs and length
of stay were assessed using the Student t test; because of
highly skewed distributions, however, we performed loga-
rithmic transformations on the two variables before per-
forming any statistical tests. Results for the two variables
were then retransformed into their natural units using
established methods of statistical simulation before final
reporting (20). For all statistical analyses, we used robust
variance estimates to adjust for the potential effects of
clustering at the hospital level (21). All statistical analyses
were performed using Stata 6.0 (Stata Corporation, College
Station, Texas).
We used results from the above analyses to estimate the
number of transfers and avoided deaths that would have
occurred if “full” or “targeted” regionalization strategies had
been applied to subjects in the Solucient EXPLORE
database.
RESULTS
The study population consisted of 13,644 subjects who
underwent nonemergent CABG at 56 hospitals in 26
different states. Of these subjects, 7,448 (54.5%) had surgery
at a teaching institution and 13,552 (99.3%) at an urban
facility. Twenty-five of the facilities had performed 200
CABG surgeries in 1997 and were classified as low-volume
centers; the remaining 31 facilities were considered high-
volume centers (Fig. 1). The mean number of surgeries
performed at each hospital was 249 (standard error, 27.4),
with 2,029 cases (14.9%) performed at low-volume centers
and 11,615 (85.1%) at high-volume facilities. Table 1
summarizes the general characteristics of the study popula-
tion at the different facilities. A significant difference in
in-hospital mortality rates was seen between low- and
high-volume facilities (3.3% vs. 1.9%; p  0.001). Com-
pared with high-volume facilities, subjects at low-volume
hospitals had trends toward greater hospital costs (low-
volume centers, $21,611 vs. high-volume centers, $19,090;
p  0.052) and longer in-hospital lengths of stay (low-
volume centers, 8.5 vs. high-volume centers, 7.9; p  0.09).
Table 2 shows results of the logistic regression model for
predicting the risk of in-hospital death. Based on the risk
model, 7,047 (51.7%) subjects were classified a priori as
minimal risk, 4,409 (32.3%) as low risk, 1,273 (9.3%) as
moderate risk, 454 (3.3%) as high risk and 461 (3.4%) as
severe risk. Predicted in-hospital mortality rates were sim-
ilar at low- and high-volume hospitals in the different risk
groups except for subjects at severe risk (25.5% at low-
volume hospitals vs. 28.0% at high-volume hospitals; p 
0.001). Overall, the observed in-hospital mortality rate was
0.2% for those subjects at minimal risk, 1.1% for those at
low risk, 2.7% for those at moderate risk, 14.1% for those at
Figure 1. Number of coronary artery bypass grafting surgeries in the 56 hospitals in the Solucient EXPLORE database.
Table 1. General Characteristics of Subjects Undergoing CABG
at Low- and High-Volume Hospitals*
Characteristics
Low-Volume
Hospitals
(n  25)
High-Volume
Hospitals
(n  31)
p
Value†
No. of subjects (%) 2,029 (14.9%) 11,615 (85.1%) —
Mean age  SD 64.5  0.2 64.6  0.1 0.87
% Women 28.5% 27.7% 0.63
% Urgent cases 31.0% 44.5% 0.15
% In-hospital deaths 3.3% 1.9% 0.001
Mean in-hospital
costs  SD, $
$21,611  $1,043 $19,090  $1,265 0.052
Mean leangth of
stay  SD, days
8.5  0.27 7.9  0.32 0.09
*Low-volume hospitals are defined as facilities with200 cases of CABG in 1997; †p
values are for the comparison between low- and high-volume hospitals.
CABG  Coronary artery bypass grafting.
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high risk and 26.9% for those at severe risk. The Hosmer-
Lemeshow goodness-of-fit test for the risk model was
nonsignificant, indicating little departure from a “perfect fit”
(p 0.62). The C-index for the risk model was 0.89, which
suggests the model had good predictive discrimination.
Table 3 shows observed in-hospital mortality rates for
subjects at low- and high-volume centers in each of the five
risk groups. Significant differences in in-hospital mortality
rates were seen between low- and high-volume centers in
subjects at moderate (5.3% vs. 2.2%; p  0.007) and high
risk (22.6% vs. 11.9%; p  0.026) (Fig. 2). While the
in-hospital mortality rate for low-risk subjects was slightly
higher at low-volume centers, this difference did not reach
statistical significance (1.7% vs. 1.0%; p  0.19). No
significant differences in in-hospital mortality rates were
found between low- and high-volume centers in those at
minimal or severe risk. In addition, no significant differences
in hospital costs or length of stay were seen between the
low- and high-volume facilities in any of the five risk groups
(Table 4). In general, the use of lower or higher volume
thresholds for defining centers (e.g., 100 or 300 annual
cases) slightly diminished—but did not eliminate—the
in-hospital mortality differences between low- and high-
volume centers in each of the five risk groups, suggesting
that 200 annual cases was a reasonable threshold.
Table 5 displays the likely outcomes of implementing
different “full” and “targeted” regionalization strategies on
subjects in the Solucient EXPLORE database. In calculat-
ing these estimates, we assumed that transferring minimal
or severe-risk subjects to high-volume centers would have
no impact on outcomes since differences in these groups
were nonsignificant. However, to favor full regionalization
strategies, we assumed that transfers of low-risk subjects to
high-volume facilities would result in better outcomes since
differences in in-hospital mortality rates were of borderline
significance in this group. Sections in Table 5 each represent
different strategies based on various definitions of a low-
volume center (e.g., 100 to 300 annual cases) and different
thresholds for transfer based on surgical risk (e.g., low risk
and above or moderate risk and above). Transfer of
moderate- and high-risk subjects from centers with less
than 200 annual cases would have resulted in 370 transfers
and 16 “avoided deaths” or, in other words, a number
needed to transfer of 23 to avoid a single death. In contrast,
full regionalization of all subjects from facilities with 200
annual cases of CABG would lead to 2,029 transfers and 20
avoided deaths, yielding a number needed to transfer of 101
to avoid a single death. When compared with targeted
regionalization, however, the incremental number needed to
transfer for full regionalization would have been 415 ([2,029
transfers  370 transfers]/[20 avoided deaths 16 avoided
deaths]).
DISCUSSION
Main findings. The objective of this study was to deter-
mine whether in-hospital mortality, hospital costs and
length of stay for CABG varied between low- and high-
volume facilities across subjects at different levels of surgical
risk. If the beneficial effects of high-volume hospitals are
concentrated in an identifiable subgroup of patients, strat-
egies of regionalization could potentially be “targeted” in
Table 2. Logistic Regression Model for Predicting Risk of In-
Hospital Death After CABG
Predictor Variable OR
Lower
95% CI
Upper
95% CI
p
Value
Age
50 years old 0.7 0.3 1.4 0.26
50 to 59 years old 1.0 — — —
60 to 69 years old 1.6 1.1 2.5 0.02
70 to 79 years old 2.2 1.5 3.4 0.001
80 years 4.1 2.4 7.0 0.001
Female gender 1.5 1.2 1.9 0.001
Urgent surgical priority 1.3 0.9 1.8 0.14
DRG
106 1.0 — — —
107 0.9 0.7 1.3 0.60
APR-DRG severity index
Minor 1.0 — — —
Moderate 1.7 0.8 3.7 0.20
Major 5.5 2.2 13.4 0.001
Extreme 80.5 36.8 175.9 0.001
APR-DRG  All Patient Refined-Diagnosis Related Groups; CABG  coronary
artery bypass grafting; CI  confidence interval; DRG  diagnosis related group;
OR  odds ratio.
Table 3. Observed In-Hospital CABG Mortality Rates at Low- and High-Volume Hospitals
Across Risk Groups*
Risk Group
(Predicted Risk of
In-Hospital Death)
Low-Volume Hospitals High-Volume Hospitals
OR
(95% CI)†
p
Value‡
No.
Survived (%)
No.
Deaths (%)
No.
Survived (%)
No.
Deaths (%)
Minimal (0.5%) 944 (99.8%) 2 (0.2%) 6,086 (99.8%) 15 (0.3%) 0.9 (0.2 to 4.0) 0.85
Low (0.5% to 2%) 701 (98.3%) 12 (1.7%) 3,658 (99.0%) 38 (1.0%) 1.6 (0.8 to 3.5) 0.19
Moderate (2% to 5%) 177 (94.7%) 10 (5.3%) 1,062 (97.8%) 24 (2.2%) 2.5 (1.3 to 4.9) 0.007
High (5% to 20%) 72 (77.4%) 21 (22.6%) 318 (81.5%) 43 (11.9%) 2.2 (1.1 to 4.2) 0.026
Severe (20%) 69 (76.7%) 21 (23.3%) 268 (72.2%) 103 (27.8%) 0.8 (0.4 to 1.5) 0.49
*Low-volume hospitals are defined as facilities with 200 cases of coronary artery bypass grafting in 1997; risk groups are based
on predicted risk of death during hospitalization for CABG; †The odds ratio corresponds to the odds of the in-hospital death
for subjects undergoing CABG at low-volume hospitals in comparison with subjects at high-volume hospitals; ‡p values are for
hypothesis test that the OR is equal to 1.
CABG  coronary artery bypass grafting; CI  confidence interval; OR  odds ratio.
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order to maximize their effectiveness and to minimize
possible disadvantages.
Several of our findings are noteworthy. First, we found no
significant differences in in-hospital mortality rates between
low- and high-volume hospitals in subjects at minimal or
low surgical risk. Since 84% of patients at low-volume
facilities were classified as either minimal or low risk,
nonselectively transferring all individuals to high-volume
hospitals, or full regionalization, is likely to have resulted in
little to no benefit in most cases. In contrast, we found
in-hospital mortality rates at low-volume facilities to be
significantly higher in subjects at moderate and high risk,
with the adjusted risk of in-hospital death more than
twofold greater when compared with high-volume centers.
Thus, the association between hospital volume and clinical
outcomes is almost entirely due to outcome differences in
moderate- and high-risk subjects and suggests that, if
feasible, targeted regionalization strategies that focus on
Figure 2. Predicted and observed in-hospital mortality rates for coronary artery bypass grafting at low- and high-volume hospitals by risk group. P values
are for the comparison of observed in-hospital mortality rates between low- (LVH) and high-volume hospitals (HVH). P*  p values 0.05.
Table 4. Observed Length of Stay and Hospital Costs of CABG at Low- and High-Volume Hospitals Across Risk Groups*
Risk Group
(Predicted Risk of In-Hospital Death) Low-Volume Hospitals High-Volume Hospitals p Value†
Minimal (0.5%)
Mean length of stay (95% CI), days 6.2 (5.9 to 6.5) 6.0 (5.8 to 6.2) 0.36
Mean in-hospital costs (95% CI), $ $16,700 ($15,500 to $18,000) $15,400 ($14,500 to $16,400) 0.18
Low (0.5% to 2%)
Mean length of stay (95% CI), days 7.9 (7.5 to 8.4) 7.6 (7.3 to 7.9) 0.36
Mean in-hospital costs (95% CI), $ $20,400 ($18,500 to $23,400) $18,000 ($16,900 to $19,300) 0.09
Moderate (2% to 5%)
Mean length of stay (95% CI), days 9.6 (9.1 to 10.0) 9.4 (9.0 to 9.8) 0.62
Mean in-hospital costs (95% CI), $ $21,900 (19,300 to $24,900) $20,500 ($19,200 to $21,800) 0.43
High (5% to 20%)
Mean length of stay (95% CI), days 9.6 (8.6 to 10.7) 11.0 (10.2 to 12.0) 0.10
Mean in-hospital costs (95% CI), $ $29,200 ($25,700 to $33,000) $28,700 ($26,100 to $31,400) 0.86
Severe (20%)
Mean length of stay (95% CI), days 12.9 (11.4 to 14.4) 12.2 (11.4 to 13.0) 0.49
Mean in hospital costs (95% CI), $ $31,700 ($28,000 to $35,600) $31,100 ($28,600 to $33,800) 0.87
*Low-volume hospitals are defined as facilities with 200 cases of CABG in 1997; risk groups are based on predicted risk of death during hospitalization for CABG; †p values
are for the comparison between low- and high-volume hospitals.
CABG  coronary artery bypass grafting; CI  confidence interval.
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identifying and referring such subjects to high-volume
hospitals might be as effective as full regionalization strat-
egies. In fact, we estimated that implementing a strategy of
targeted regionalization (i.e., transferring subjects at
moderate-risk or higher from hospitals with less than 200
annual cases) in our study population would have resulted in
370 transfers and avoided 16 deaths. Full regionalization
would have led to 1,659 more transfers to avert four
additional deaths or an incremental number needed to
transfer of 415 to avoid a single death.
Next, we found no significant differences between low-
and high-volume centers in those subjects who were at
severe risk for an in-hospital death. We offer three possible
explanations for this finding. First, given the small number
of severe-risk subjects at low-volume centers (n  90), this
result might just reflect random statistical variation. Second,
since we broadly stratified subjects at severe risk—predicted
in-hospital mortality rates between 20% and 100%—we
might have missed important differences in surgical risk
between severe subjects at low- and high-volume hospitals.
The fact that we found a statistically significant difference
between the predicted in-hospital mortality rates of severe-
risk subjects at low- and high-volume facilities (25.5% vs.
28.0%; p  0.001) supports this hypothesis and suggests
that, at high-volume hospitals, these subjects had, on
average, higher surgical risk. Finally, we used the APR-
DRG, a discharge abstract-based case-mix measure, to
adjust for severity of illness in our risk model. Use of the
APR-DRG might have resulted in inappropriate adjust-
ment for postprocedural complications, not just pre-existing
risk factors, in our risk model and potentially minimized any
differences that actually exist between low- and high-
volume centers for subjects at severe risk.
Regionalization in previous reports. What are the possi-
ble disadvantages of regionalization? First, regionalization
largely ignores patient choices and preferences for health-
care, which current evidence suggests could be substantial.
A recent study by Finlayson et al. (21), for instance,
demonstrated that 100% of subjects given a standardized
scenario favored having high-risk surgery performed at a
local hospital if outcomes were identical to those at regional
centers. Furthermore, nearly 75% of subjects still preferred
surgeries at local hospitals when given successive scenarios
in which local in-hospital mortality rates were higher than
rates at regional centers (22). Second, regionalization could
result in considerable travel burdens for patients and their
families, particularly for those in distant rural areas. This is
potentially important since some evidence suggests that, as
distances between patients and providers increase, access to
care worsens and healthcare services are underutilized (23).
Third, regionalization could have an impact on the
economic viability of small- to moderate-sized healthcare
facilities. Without adequate CABG volume, these hospitals
would lose a substantial amount of revenue and have a
difficult time recruiting and retaining cardiothoracic sur-
geons (24). Consequently, a facility’s loss of CABG patients
would likely extend to other cardiothoracic-related services
such as coronary angioplasty or thoracic surgery or to its
ability to provide emergency surgical services. While it does
not entirely eliminate several of these potential disadvan-
tages, targeted regionalization does minimize them. In
addition, targeted regionalization is likely to be a more
acceptable alternative for low-volume centers and might
avoid the “political firestorm” that others have suggested
will occur over policies of full regionalization (25).
We are aware of only one other study examining whether
clinical outcomes of CABG differed between low- and
high-volume hospitals in a specific subgroup of patients. In
1987, Showstack and colleagues (26) demonstrated that, in
comparison with scheduled cases, in-hospital mortality dif-
ferences between low- and high-volume hospitals were
more marked in nonscheduled or emergent surgeries. The
authors concluded that the greater skills and experiences of
surgical teams at high-volume hospitals were more valuable
in CABG during high-risk situations. However, since
emergent cases account for a small number of total CABG
surgeries and such cases are often difficult to transfer,
selectively regionalizing emergent cases alone is unlikely to
have much impact as an isolated policy measure.
In contrast with differences in in-hospital mortality rates,
we did not find that hospital costs or lengths of stay differed
significantly between low- and high-volume centers after
subjects were stratified into the five risk groups. While it is
assumed that regionalizing CABG to high-volume centers
Table 5. Estimated Outcomes of Full and Targeted Regionalization of CABG*
Volume
Threshold†
Full
Regionalization
Targeted Regionalization
(Moderate Risk and Above)
Targeted Regionalization
(Low Risk and Above)
100 No. of transfers 682 105 323
No. of deaths avoided 6 2 6
No. needed to transfer to avoid a death 114 53 54
200 No of transfers 2,029 370 1,083
No. of deaths avoided 20 16 20
No. needed to transfer to avoid a death 101 23 54
300 No of transfers 4,871 857 2,499
No. of deaths avoided 24 15 24
No. needed to transfer to avoid a death 203 57 104
*Table assumes beneficial effect of high-volume hospitals in subjects at low, moderate or high risk; †Patients are transferred from facilities with an annual number of CABG cases
less than the volume threshold to facilities with a higher number of annual cases than the volume threshold.
CABG  coronary artery bypass grafting.
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would reduce hospital costs by providing economies of scale,
eliminating wasteful duplication and improving clinical
outcomes, direct evidence for such benefits is scarce and, at
times, conflicting (27,28). Most recently, Menke and Wray
(29) found that the long-term cost savings from regional-
ization of CABG to high-volume hospitals could be sub-
stantial; however, their estimates were based on a study of
Veterans Affairs hospitals and might not be generalizable to
the rest of the healthcare system. Without better data, there
is a legitimate concern that regionalization could actually
increase overall costs by leading to costly transfers or
centralizing services at large teaching hospitals where care
may be, in fact, more expensive (30).
Study limitations. Our findings should be interpreted in
the context of the following limitations. First, this study was
observational in nature and does not establish causal rela-
tionships. We can only speculate that higher surgical vol-
umes at institutions lead to better in-hospital outcomes (i.e.,
the “practice makes perfect” hypothesis) (5). This is impor-
tant to note since it has been suggested that at least part of
the differences in outcomes between low- and high-volume
centers might be due to the fact that better hospitals attract
more patients (i.e., the “selective referral” hypothesis) (5).
Second, we were unable to include all the clinical indexes
that have been linked to adverse CABG outcomes in our
risk model, such as a history of previous CABG, poor left
ventricular function, cerebrovascular disease or peripheral
vascular disease (13). Instead, we used the APR-DRG, a
discharge abstract-based case-mix measure, to adjust for
overall severity of illness and, while it has been established as
a useful tool for estimating in-hospital death, length of stay
and hospital costs for CABG, it is likely that some degree of
residual confounding existed. Moreover, since the APR-
DRG uses discharge diagnoses to risk-stratify patients, it is
unable to distinguish between preexisting risk factors and
postprocedure complications, which can also effect hospital
mortality. This last issue is likely to explain, in part, the risk
model’s high C-index of 0.89.
Third, we focused on in-hospital mortality rates as our
primary clinical outcome. Thus, we could not account for
transfers and differential length of stay patterns between
facilities or examine the impact of high-volume hospitals on
the incidence of important complications such as stroke,
renal failure, deep sternal wound infection or long-term
mortality and function. Fourth, we were unable to deter-
mine the degree to which targeted regionalization already
exists among the hospitals in the Solucient EXPLORE
database. The distribution of patients based on surgical risk
was similar between low- and high-volume centers, how-
ever, which suggests that a substantial number of high-risk
patients were not being selectively transferred to high-
volume centers. Finally, the Solucient EXPLORE database
was composed of hospitals interested in providing clinical
and economic data for purposes of comparative benchmark-
ing activity; these facilities may not be representative of all
hospitals performing CABG in the U.S.
Conclusions. Despite these limitations, our results may
have important policy implications. Our finding that in-
hospital mortality rates for CABG differed at low- and
high-volume hospitals in subjects at moderate and high
risk—but not in those at minimal or low risk—suggests that
targeted regionalization might be a feasible strategy for
effectively balancing the clinical benefits of regionalization
with patients’ desires for choice and access. In addition,
targeted regionalization is likely to be a more acceptable
option for local providers and hospitals, given the realities of
the current healthcare system. Of course, further research
will be needed to confirm our findings using larger, CABG-
specific clinical datasets and possibly through future clinical
trials.
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